Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Lifecore Biomedical Announced That It Has Finalized A Series Of Updated Commercial Arrangements With Its Long-Term Commercial Hyaluronic Acid And CDMO Customer, Alcon To Extend And Expand The Existing CDMO Relationship

Author: Benzinga Newsdesk | January 05, 2024 09:06am

Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements

Lifecore receives amendment and waiver for its term debt facility with Alcon and BMO

Posted In: ALC LFCR